These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37272673)

  • 21. Skin Biopsy as a Novel Diagnostic Aid in Immune-Mediated Neuropathies.
    Min YG; Ju W; Ha YE; Ban JJ; Shin JY; Kim SM; Hong YH; Park SH; Sung JJ
    J Neuropathol Exp Neurol; 2022 Nov; 81(12):1018-1025. PubMed ID: 36137254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nerve conduction blocks and peripheral neuropathies].
    Lefaucheur JP; Boërio D; Créange A
    J Soc Biol; 2006; 200(4):307-21. PubMed ID: 17652968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism.
    Yuki N; Uncini A
    Muscle Nerve; 2014 May; 49(5):629-35. PubMed ID: 24477718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.
    Pillai AM; Thaxton C; Pribisko AL; Cheng JG; Dupree JL; Bhat MA
    J Neurosci Res; 2009 Jun; 87(8):1773-93. PubMed ID: 19185024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The autoimmune vulnerability of the node of Ranvier.
    Querol L; Delmont E; Lleixà C
    J Peripher Nerv Syst; 2023 Jul; 28 Suppl 3():S12-S22. PubMed ID: 37272737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders.
    Shelly S; Dubey D; Mills JR; Klein CJ
    Handb Clin Neurol; 2024; 200():239-273. PubMed ID: 38494281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiganglioside antibodies in neurological diseases.
    Wanleenuwat P; Iwanowski P; Kozubski W
    J Neurol Sci; 2020 Jan; 408():116576. PubMed ID: 31726381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.
    Camdessanché JP; Antoine JC; Honnorat J; Vial C; Petiot P; Convers P; Michel D
    Brain; 2002 Jan; 125(Pt 1):166-75. PubMed ID: 11834602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undiagnosed neuropathies: the impact of ancillary investigations.
    Thomas PK
    Baillieres Clin Neurol; 1996 Mar; 5(1):157-70. PubMed ID: 8732206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etiologic spectrum of biopsy-proven peripheral neuropathies in childhood from a resource-poor setting.
    Krishnan P; Mahadevan A; Bindu PS; Chickabasaviah YT; Taly AB
    J Child Neurol; 2015 May; 30(6):707-15. PubMed ID: 25038122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.
    Kuwabara S; Ogawara K; Mizobuchi K; Koga M; Mori M; Hattori T; Yuki N
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):191-5. PubMed ID: 10644786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis 1-associated neuropathies: a reappraisal.
    Drouet A; Wolkenstein P; Lefaucheur JP; Pinson S; Combemale P; Gherardi RK; Brugières P; Salama J; Ehre P; Decq P; Créange A
    Brain; 2004 Sep; 127(Pt 9):1993-2009. PubMed ID: 15289270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Axonal attenuation and secondary segmental demyelination in myeloma neuropathies.
    Ohi T; Kyle RA; Dyck PJ
    Ann Neurol; 1985 Mar; 17(3):255-61. PubMed ID: 2986526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic findings in multifocal motor neuropathy.
    Katz JS; Wolfe GI; Bryan WW; Jackson CE; Amato AA; Barohn RJ
    Neurology; 1997 Mar; 48(3):700-7. PubMed ID: 9065551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects.
    Manso C; Querol L; Mekaouche M; Illa I; Devaux JJ
    Brain; 2016 Jun; 139(Pt 6):1700-12. PubMed ID: 27017186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conduction block in immune-mediated neuropathy: paranodopathy versus axonopathy.
    Garg N; Park SB; Howells J; Vucic S; Yiannikas C; Mathey EK; Nguyen T; Noto Y; Barnett MH; Krishnan AV; Spies J; Bostock H; Pollard JD; Kiernan MC
    Eur J Neurol; 2019 Aug; 26(8):1121-1129. PubMed ID: 30882969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-neurofascin autoantibody and demyelination.
    Kira JI; Yamasaki R; Ogata H
    Neurochem Int; 2019 Nov; 130():104360. PubMed ID: 30582947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies.
    Trojaborg W; Hays AP; van den Berg L; Younger DS; Latov N
    Muscle Nerve; 1995 Jul; 18(7):730-5. PubMed ID: 7540258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic neuropathies - chronic inflammatory demyelinating neuropathy and its variants.
    Ramchandren S; Lewis RA
    Front Neurol Neurosci; 2009; 26():12-25. PubMed ID: 19349703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.